Clinical Trials

MainTitle

Computer-Assisted HIV Prevention for Young Drug Users

The recruitment status of this study is unknown.

Verified August 2008

Sponsor
National Development and Research Institutes, Inc.

Collaborator
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center

Information provided by (Responsible Party)
National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier
NCT00182585

First received: September 10, 2005
Last updated: August 11, 2008
Last Verified: August 2008
History of Changes
Purpose

Purpose

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Condition Intervention
HIV

Procedure : computer-based HIV, STD & Hepatitis Education
Procedure : educator-delivered HIV, STD and Hepatitis education

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Computer-Assisted HIV Prevention for Young Drug Users

Further study details as provided by National Development and Research Institutes, Inc.:

Primary Outcome Measures

  • HIV risk behavior
Secondary Outcome Measures:
  • knowledge related to HIV, Hepatitis, STDs
  • behavioral intentions
  • attitudes toward risk-reduction behavior
  • feedback on intervention

Estimated Enrollment: 56
Study Start Date: August 2004

Detailed Description:

Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

Eligibility

Eligibility

Ages Eligible for Study: 13 Years to 18 Years  
Sexes Eligible for Study: All  
Accepts Healthy Volunteers: No  

Criteria

Inclusion Criteria:

  • Aadolescents in outpatients substance abuse treatment
  • Ages 13 - 18 years
  • Within first month of treatment entry

Exclusion Criteria:

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182585

Locations

United States, New York
Daytop
Brooklyn, New York, United States, 11217
St. Luke's-Hospital, CAPA Program
New York, New York, United States, 10025

Sponsors and Collaborators

National Development and Research Institutes, Inc.
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center

Investigators

Principal Investigator: Lisa Marsch, PhD National Development and Research Institutes, Inc.
More Information

More Information


Responsible Party: National Development and Research Institutes, Inc.  
ClinicalTrials.gov Identifier: NCT00182585   History of Changes  
Other Study ID Numbers: R01DA015964  
Study First Received: September 10, 2005  
Last Updated: August 11, 2008  

Keywords provided by National Development and Research Institutes, Inc.:

HIV
hepatitis
STDs
adolescents
addiction
treatment
prevention
HIV and related risk behavior among youth in drug treatment

ClinicalTrials.gov processed this data on December 15, 2017
This information is provided by ClinicalTrials.gov.